1.Directly prevents HIV from infecting CD4 T T-cells 2.Activates the Th1 immune response, i.e., turns on macrophages that actually ingest HIV itself, killer T actually T-lymphocytes that destroy HIV HIV-infected cells and other HIV cells HIV-fighting immune system responses Currently it’s the only HIV/AIDS therapy to achieve this.
MODE 1 By binding to specific proteins onthe outer surface of HIV particles,Immunotech IPF directly prevents HIV from infecting CD4 T T-cells.
• HIV gp120 binds to CD4 on TT-cells and then to a coreceptor. • Causes gp41 attachment to the cell membrane = virus-cell fusion and HIV infection. • IPF inactivates gp120 and gp41 =no HIV binding to cells and no HIV infection. MODE 2 Immunotech IPF binds to T-cells and turns on Th1 immune system responses that kill HIV and HIV- infected cells. Not done by any other HIV/AIDS therapies.
IFN-?,IL-2 and TNF-? are cytokines, small proteins released by T-cells and received by other cells to generate a specific immune response.